Functional hallucinations in schizophrenia responding to adjunctive sodium valproate

Area of Science:

• Neuroscience
• Psychiatry
• Clinical Psychology

Background:

• Functional hallucinations are rare, stimulus-triggered sensory experiences within the same modality.
• Antipsychotic medications, like risperidone, are standard treatment for schizophrenia but lack universal efficacy.

Observation:

• A patient with paranoid schizophrenia presented with persistent functional hallucinations triggered by factory machine noise.
• These hallucinations persisted despite adequate risperidone dosage, which controlled other psychotic symptoms.

Findings:

• The addition of sodium valproate, gradually increased to 1700 mg/day, led to significant improvement in functional hallucinations.
• This intervention enabled the patient to resume employment, indicating a positive clinical outcome.

Implications:

• Sodium valproate may be a viable therapeutic option for refractory functional hallucinations in schizophrenia.
• Further research into the neurobiological mechanisms underlying this response is warranted.